Quarterly report pursuant to Section 13 or 15(d)

NOTE 6: MARKETABLE SECURITIES

v3.19.2
NOTE 6: MARKETABLE SECURITIES
6 Months Ended
Jun. 30, 2019
Notes  
NOTE 6: MARKETABLE SECURITIES

NOTE 6: MARKETABLE SECURITIES

 

The Company utilizes FAS 115 “Accounting for Certain Investments in Debt and Equity Securities”. The Company received marketable securities, 10,300,000 fully paid ordinary unrestricted shares in Impression Healthcare Limited (Australian Company), traded on Australian Security Exchange by the code IHL as part of the agreement and letter of intent (LOI). The Company categorize these securities as trading securities and report them at fair value, with unrealized gains and losses included in earnings. The Company recorded securities at FMV at the price of A$0.02 per share and exchange rate of $0.74 AUD/USD valued $150,000. On June 30, 2019 the stock price was A$ 0.041 per share as quoted on www.asx.com.au and exchange rate of $0.70 AUD/USD as quoted on www.oanda.com and had FMV $288,400 as of June 30, 2019. As of June 30, 2019 the change to the FMV in marketable securities for the period resulted in unrealized gain of $113,400, and $138,400 for three and six months respectively.